Using rapid testing to guide antibiotic choice in ventilator pneumonia
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether using a rapid test to find the exact bacteria causing your pneumonia can help doctors choose the right antibiotics faster, which might improve your recovery. The study compares this approach to usual care in patients on ventilators.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have been in the hospital and on a ventilator for at least 48 hours.
- You have signs of pneumonia, like fever, purulent mucus, or low oxygen, and a fluid sample from your lungs will be taken within 12 hours.
- You are already starting antibiotics for the pneumonia.
- You cannot have a severely weakened immune system (from certain diseases, chemotherapy, anti-rejection drugs, or high-dose steroids).
- You cannot be allergic to beta-lactam antibiotics (like penicillin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to quickly diagnose pneumonia in children on breathing machines in the ICU. It uses information from the body and germs to find the right treatment faster.
This study looks at when to start antibiotics for a lung infection you may have gotten while on a breathing machine. It compares starting them right away versus waiting for the test results to be sure you need them.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
This trial tests a treatment that uses special viruses (called phages) to kill antibiotic-resistant bacteria causing pneumonia in people on ventilators. If you're eligible, this new approach might help fight the infection when standard antibiotics aren't working well.
This study tests whether adjusting antibiotics early, based on test results, can improve treatment for patients with severe pneumonia who are on a breathing machine in the intensive care unit. It aims to make antibiotic use more effective and reduce side effects.
Hear when a new Ventilator Associated Pneumonia ( VAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.